Drug intelligence / Profile preview

neochlorogenic acid

Development stage
Preclinical
Modality
Small Molecules
01

Overview

Neochlorogenic acid is a natural polyphenolic compound belonging to the quinic acids and derivatives class, found in various fruits, vegetables, and plants including peaches, quince, chicory, white cabbage, and grape wine[1][2][9]. It is an isomer of chlorogenic acid. Neochlorogenic acid is recognized for its antioxidant, antibacterial, antiviral, anti-inflammatory, antifungal, hepatoprotective, cardioprotective, neuroprotective, anti-obesity, anti-diabetes, and anticarcinogenic properties[1][3]. In vitro studies indicate it inhibits pro-inflammatory cytokines such as TNF-α and IL-1β, suppresses iNOS and COX-2 protein expression, and reduces LPS-induced NO production in microglial cells, suggesting a neuroprotective effect through anti-inflammatory pathways[1][8]. There is no evidence it was developed as a pharmaceutical by a specific company; it is primarily studied as a natural bioactive compound[3].

Other names
3-O-caffeoylquinic acidneochlorogenatetrans-5-O-caffeoylquinic acidtrans5-O-caffeoylquinic acidtrans 5-O-caffeoylquinic acid(1R,3R,4S,5R)-3-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)RELA (Nuclear Factor Kappa B Subunit p65)MAPK14 (p38 mitogen-activated protein kinase alpha)TNFA (Tumor necrosis factor alpha (soluble))NOS2 (Nitric Oxide Synthase 2)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on neochlorogenic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on neochlorogenic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call